Vista Pharma's Board approved Q1 results, showing a net loss of Rs. 0.99 Cr with Nil revenue.

VP

Vista Pharmaceuticals Ltd524711 · Filed with the exchange

Facing significant 'going concern' doubts due to NPA and negative working capital, the company expects Rs. 9.22 Cr from warrant subscribers to support operations.

Read the original filing(PDF)

No comments yet. Be the first.

More from Vista Pharmaceuticals Ltd

All announcements

Others14-08-2026
Result
Important15-07-2026
Company Update
Insider Trade25-06-2026
Insider Trading / SAST
Important29-05-2026
Company Update
Board Meeting19-05-2026
Board Meeting
Others29-04-2026
Others

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.